Treatment of patients with refractory atopic dermatitis sensitized to house dust mites by using sublingual allergen immunotherapy

Annals of Dermatology

Volumn 27, Issue 1, 2015, Pages 82-86

  Choi, Joon Seok ^a   Ryu, Ha Ryeong ^a   Yoon, Cheol Hyun ^a   Kim, Ji Hoon ^a   Baek, Jin Ok ^a   Roh, Joo Young ^a   Lee, Jong Rok ^a  

^a Gachon University   (South Korea)

Author keywords

Atopic dermatitis; Pyroglyphidae; Sublingual immunotherapy

Indexed keywords

EID: 84922270825     PISSN: 10139087     EISSN: 20053894     Source Type: Journal    
DOI: 10.5021/ad.2015.27.1.82     Document Type: Article

References (15)

1. Scalabrin DM, Bavbek S, Perzanowski MS, Wilson BB, Platts-Mills TA, Wheatley LM. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 1999;104: 1273-1279.
2. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006;61:151-165.
3. Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006;61:202-205.
4. Nahm DH, Kim ME. Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin. Yonsei Med J 2012;53:158-163.
5. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-S334.
6. Frew AJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 2001;107:441-444.
7. Novak N, Simon D. Atopic dermatitis-from new pathophysiologic insights to individualized therapy. Allergy 2011;66:830-839.
8. Agostinis F, Tellarini L, Canonica GW, Falagiani P, Passalacqua G. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Allergy 2005;60:133.
9. Grosclaude M, Bouillot P, Alt R, Leynadier F, Scheinmann P, Rufin P, et al. Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study. Int Arch Allergy Immunol 2002;129:248-253.
10. Mastrandrea F, Serio G, Minelli M, Minardi A, Scarcia G, Coradduzza G, et al. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol Immunopathol (Madr) 2000; 28:54-62.
11. Petrova SIu, Berzhets VM, Al'banova VI, Bystritskaia TF, Petrova NS. Immunotherapy in the complex treatment of patients with atopic dermatitis with sensitization to house dust mites. Zh Mikrobiol Epidemiol Immunobiol 2001;(1): 33-36.
12. Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, et al. Sublingual immunotherapy in mitesensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007;120:164-170.
13. Akdis CA, Barlan IB, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy 2006; 61(Suppl 81):11-14.
14. Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008;63: 720-727.
15. Cadario G, Galluccio AG, Pezza M, Appino A, Milani M, Pecora S, et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin 2007; 23:2503-2506.